Table 4. Intended and undertaken therapy in patients with acute PAD.
| intended therapy | number of patients | undertaken therapy * | |||||
| Σ | refused | agree-ment | disagree-ment * | ||||
| surgical treatment | 70/93 | 2/70 | 56/68 | 12/68 | |||
| (75%) | (3%) | (81%) | (19%) | ||||
| Thrombectomy | 48 | 1 | 35 | 4 | major amputation | ||
| 5 | additional endovascular catheter-directed thrombolysis | ||||||
| 3 | additional PTA ± Stenting | ||||||
| bypass surgery | |||||||
| aortoiliac / aortofemoral | 10 | 10 | |||||
| femoropopliteal | 4 | 4 | |||||
| femorocrural | 3 | 3 | |||||
| Amputation | |||||||
| major | 4 | 1 | 3 | ||||
| minor | 1 | 1 | |||||
| endovascular treatment | 12/93 | 2/12 | 8/10 | 2/10 | |||
| (13%) | (17%) | (80%) | (20%) | ||||
| PTA ± Stenting | |||||||
| pelvic arteries | 4 | 4 | |||||
| thigh arteries | 3 | 1 | 2 | ||||
| - calf arteries | 2 | 1 | 1 | ||||
| thrombectomy | 2 | 1 | 1 | conservative; endovascular bypass recanalization failed | |||
| thrombolysis | 1 | 1 | conservative; Catecholamine induced circulatory disorder | ||||
| non invasive treatment | 11/93 | ||||||
| (12%) | |||||||
| no therapeutic option for endovascular or surgical revascularization | 6 | ||||||
| catecholamine induced circulatory disorder | 1 | ||||||
| spontaneous improvement | 1 | ||||||
| inoperable due to comorbidities | 3 | ||||||
*The conducted therapy is given for all patients planned to undergo endovascular or surgical treatment in case of disagreement. Note that diagnostic confidence of all run-off CTA studies in patients with acute PAD was rated to be sufficient (DC+). PTA = percutaneous transluminal angioplasty.